Literature DB >> 1845895

Polyomavirus replication in mice: influences of VP1 type and route of inoculation.

T W Dubensky1, R Freund, C J Dawe, T L Benjamin.   

Abstract

Patterns of polyomavirus replication and spread have been studied following inoculation of virus into newborn mice. Levels of virus replication in different tissues were followed in situ by using whole mouse section blots and immunoperoxidase staining for the major capsid protein VP1, as well as by tissue extraction and direct quantitation of viral DNA and infectious virus. Patterns of replication and spread were compared between the "high tumor" strain (inducing a high incidence of tumors) PTA and and the "low tumor" strain (inducing a low incidence of tumors) RA, following different routes of inoculation. The ability to induce a high tumor profile correlated with the ability to establish disseminated productive infection, with the kidney as a major site of amplification. Furthermore, results with PTA-RA recombinant viruses and site-directed mutants showed that the VP1 specificity of PTA, demonstrated earlier to be a critical determinant for induction of a high tumor profile (R. Freund, A. Calderone, C. J. Dawe, and T. L. Benjamin, J. Virol. 65:335-341, 1991), is also critical for amplification in the kidney and for establishment of disseminated infections.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1845895      PMCID: PMC240523     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  14 in total

1.  Necrotizing arterial lesions in mice-bearing tumors induced by polyoma virus.

Authors:  C J Dawe; R Freund; J P Barncastle; T W Dubensky; G Mandel; T L Benjamin
Journal:  J Exp Pathol       Date:  1987

2.  Analysis of host range of nontransforming polyoma virus mutants.

Authors:  E Goldman; T L Benjamin
Journal:  Virology       Date:  1975-08       Impact factor: 3.616

3.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

4.  Phosphorylation of middle T by pp60c-src: a switch for binding of phosphatidylinositol 3-kinase and optimal tumorigenesis.

Authors:  D A Talmage; R Freund; A T Young; J Dahl; C J Dawe; T L Benjamin
Journal:  Cell       Date:  1989-10-06       Impact factor: 41.582

5.  Efficient transfer of large DNA fragments from agarose gels to diazobenzyloxymethyl-paper and rapid hybridization by using dextran sulfate.

Authors:  G M Wahl; M Stern; G R Stark
Journal:  Proc Natl Acad Sci U S A       Date:  1979-08       Impact factor: 11.205

6.  Duplication of noncoding sequences in polyomavirus specifically augments the development of thymic tumors in mice.

Authors:  R Freund; C J Dawe; T L Benjamin
Journal:  J Virol       Date:  1988-10       Impact factor: 5.103

7.  Polyomavirus tumor induction in mice: effects of polymorphisms of VP1 and large T antigen.

Authors:  R Freund; A Calderone; C J Dawe; T L Benjamin
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

8.  A single-amino-acid substitution in polyomavirus VP1 correlates with plaque size and hemagglutination behavior.

Authors:  R Freund; R L Garcea; R Sahli; T L Benjamin
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

9.  The primary site of replication alters the eventual site of persistent infection by polyomavirus in mice.

Authors:  T W Dubensky; L P Villarreal
Journal:  J Virol       Date:  1984-05       Impact factor: 5.103

10.  Studies of mouse polyoma virus infection. 1. Procedures for quantitation and detection of virus.

Authors:  W P ROWE; J W HARTLEY; J D ESTES; R J HUEBNER
Journal:  J Exp Med       Date:  1959-04-01       Impact factor: 14.307

View more
  43 in total

1.  Large-plaque mutants of Sindbis virus show reduced binding to heparan sulfate, heightened viremia, and slower clearance from the circulation.

Authors:  A P Byrnes; D E Griffin
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

2.  Kilham polyomavirus: activation of gene expression and DNA replication in mouse fibroblast cells by an enhancer substitution.

Authors:  S Zhang; G Magnusson
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

Review 3.  Natural biology of polyomavirus middle T antigen.

Authors:  K A Gottlieb; L P Villarreal
Journal:  Microbiol Mol Biol Rev       Date:  2001-06       Impact factor: 11.056

4.  Tumor induction by a transformation-defective polyoma virus mutant blocked in signaling through Shc.

Authors:  R Bronson; C Dawe; J Carroll; T Benjamin
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

Review 5.  Genotypes, archetypes, and tandem repeats in the molecular epidemiology and pathogenesis of JC virus induced disease.

Authors:  Walter J Atwood
Journal:  J Neurovirol       Date:  2003-10       Impact factor: 2.643

6.  Specificity and affinity of sialic acid binding by the rhesus rotavirus VP8* core.

Authors:  Philip R Dormitzer; Zhen-Yu J Sun; Ola Blixt; James C Paulson; Gerhard Wagner; Stephen C Harrison
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

7.  Polyomavirus tumor induction in mice: effects of polymorphisms of VP1 and large T antigen.

Authors:  R Freund; A Calderone; C J Dawe; T L Benjamin
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

8.  A single-amino-acid substitution in polyomavirus VP1 correlates with plaque size and hemagglutination behavior.

Authors:  R Freund; R L Garcea; R Sahli; T L Benjamin
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

9.  Mutations in the VP1 coding region of polyomavirus determine differentiating stage specificity.

Authors:  L Ricci; R Maione; C Passananti; A Felsani; P Amati
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

10.  Changes in frequency, morphology, and behavior of tumors induced in mice by a polyoma virus mutant with a specifically altered oncogene.

Authors:  R Freund; C J Dawe; J P Carroll; T L Benjamin
Journal:  Am J Pathol       Date:  1992-12       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.